Health risk assessment of ochratoxin a for all age-sex strata in a market economy

Food Additives and Contaminants - Part A

Volumn 27, Issue 2, 2010, Pages 212-240

  Kuiper Goodman, T ^a   Hilts, C ^a,b   Billiard, S M ^a,b   Kiparissis, Y ^a,b   Richard, I D K ^a,b   Hayward, S ^a,b  

^a Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals   (Canada)

^b Postal Locator: 2204C   (Canada)

Author keywords

Children; Exposure; Guidelines; Margin of exposure (MOE); Mycotoxin; Negligible cancer risk intake (NCRI); Ochratoxin A (OTA); Probabilistic; Renal cancer; Risk management; Risk metrics; Soy formula; Tolerable daily intake (TDI)

Indexed keywords

OCHRATOXIN;

ADOLESCENT; ADULT; AGE DETERMINATION; AGED; ARTICLE; BEER; BODY WEIGHT; CANCER RISK; CARCINOGENICITY; CHILD; COFFEE; CONTROLLED STUDY; ECONOMIC ASPECT; FEMALE; FOOD CONTAMINATION; FOOD INTAKE; GENOTOXICITY; HEALTH HAZARD; HUMAN; INFANT; MALE; MARKET; MONTE CARLO METHOD; NEPHROTOXICITY; NONHUMAN; OAT; PRIORITY JOURNAL; PROBABILITY; RICE; RISK ASSESSMENT; SEX RATIO; WINE;

AVENA; TRITICUM AESTIVUM;

EID: 71649087422     PISSN: 19440049     EISSN: 14645122     Source Type: Journal    
DOI: 10.1080/02652030903013278     Document Type: Article

References (91)

1. Bakker M, Pieters MN. 2002. Risk assessment of ochratoxin A in the Netherlands. Report Number 388802025/2002. RIVM, Bilthoven (the Netherlands).
2. Barlow S, Renwick AG, Kleiner J, Bridges JW, Busk L, Dybing E, Edler L, Eisenbrand G, Fink-Gremmels J, Knaap A, Kroes R, Liem D, Muller DJG, Page S, Rolland V, Schlatter J, Tritscher A, Tueting W, Wurtzen G. 2006. Risk assessment of substances that are both genotoxic and carcinogenic: report of an International Conference organized by EFSA and WHO with support of ILSI Europe. Food Chem Toxicol. 44:1636-1650.
3. Barrett JC. 1992. Mechanisms of action of known human carcinogens. In: Vainio H, Magee PN, McGregor DB, McMichael AJ, editors. Mechanisms of carcinogenesis in risk identification. Scientific Publications Number 116.
4. Lyon (France): International Agency for Research on Cancer (IARC). pp. 115-134.
5. Bendele AM, Carlton WW, Krogh P, Lillehoj EB. 1985. Ochratoxin A carcinogenesis in the (C57BL/6J × C3H)F1 mouse. J Natl Canc Inst. 75:733-742.
6. Brambilla G, Martelli A. 2004. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens. Toxicology. 196:1-19.
7. Bullerman LB, Bianchini A. 2007. Stability of mycotoxins during food processing. Int J Food Microbiol. 119:140-146.
8. Carriquiry AL, Camañno-Garcia G. 2006. Evaluation of dietary intake data using the tolerable upper intake levels. J Nutr. 136: 507S-513S.
9. Castegnaro M, Mohr U, Pfohl-Leszkowicz A, Estève J, Steinmann J, Tillmann T, Michelon J, Bartsch H. 1998. Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int J Cancer. 77:70-75.
10. Counil É, Verger P, Volatier JL. 2005. Handling of contamination variability in exposure assessment: a case study with ochratoxin A. Food Chem Toxicol. 43:1541-1555.
11. Counil É, Verger P, Volatier JL. 2006. Fitness-for-purpose of dietary survey duration: a case-study with the assessment of exposure to ochratoxin A. Food Chem Toxicol. 44:499-509.
12. Crump KS. 1995. Calculation of benchmark doses from continuous data. Risk Analys. 15:79-89.
13. Crump KS, Van Landingham C. 1996. BENCH_C: a Fortran program to calculate benchmark doses from continuous data. Ruston (LA): ICF Consulting.
14. Dourson ML, Felter SP, Robinson D. 1996. Evolution of science-based uncertainty factors in noncancer risk assess-ment. Regulat Toxicol Pharmacol. 24:108-120.
15. European Food Safety Authority (EFSA). 2005. Opinion of the Scientific Committee on a request from EFSA related to a harmonized approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA J. 282:1-31.
16. European Food Safety Authority (EFSA). 2006. Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to ochratoxin A in food. EFSA J. 365:1-56.
17. Faucet V, Pfohl-Leszkowicz A, Dai J, Castegnaro M, Manderville RA. 2004. Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem Res Toxicol. 17:1289-1296.
18. Fink-Gremmels J. 2005. Conclusions from the Workshops on ochratoxin A in Food: Recent Developments and Significance, organized by ILSI Europe in Baden (Austria), 29 June-1 July 2005. Food Addit Contam. 22(Suppl. 1):1-5.
19. Galtier P, Alvinerie M, Charpenteau JL. 1981. The pharmacokinetic profiles of ochratoxin A in pigs, rabbits and chickens. Food Cosmet Toxicol. 19:735-738.
20. Gautier J, Richoz J, Welti DH, Markovic J, Gremaud E, Guengerich FP, Turesky RJ. 2001. Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes. Chem Res Toxicol. 14:34-45.
21. Gay C. 2000. Estimation of population distributions of habitual nutrient intake based on a short-run weighted food diary. Br J Nutr. 83:287-293.
22. Gibney MJ, van der Voet H. 2003. Introduction to the Monte Carlo project and the approach to the validation of conceptual models of dietary exposure to selected food chemicals. Food Addit Contam. 20:S1-S7.
23. Gilbert J, Brereton P, MacDonald S. 2001. Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit Contam. 18:1088-1093.
24. Gross-Steinmeyer K, Weymann J, Hege HG, Metzler M. 2002. Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes. J Agricult Food Chem. 50:938-945.
25. Guenther PM, Kott PS, Carriquiry AL. 1997. Development of an approach for estimating usual nutrient intake distributions at the population level. J Nutr. 127:1106-1112.
26. Hagelberg S, Hult K, Fuchs R. 1989. Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J Appl Toxicol. 9:91-96.
27. Hard GC. 2000. Histopathologic evaluation of rat kidney from toxicity and carcinogenicity studies with ochratoxin A. Expert report submitted to the Joint Expert Committee on Food Additives by the International Life Sciences Institute, Washington, DC.
28. Hoffmann K, Boeing H, Dufour A, Volatier JL, Telman J, Virtanen M, Becker W, De Henauw S. 2002. Estimating the distribution of usual dietary intake by short-term measurements. Eur J Clin Nutr. 56:S53-S62.
29. Howe RB. 1995. THRESH: a computer program to compute a reference dose from quantal animal toxicity data using the benchmark dose method. Ruston (LA): ICF Kaiser Engineers.
30. International Agency for Research on Cancer (IARC). 1993. Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins. Monographs on the Evaluation of Carcinogenic Risks to Humans Number 56. Lyon (France): IARC Press. pp. 489-521.
31. Joint Expert Committee on Food Additives (JECFA). 1991. Ochratoxin A. Joint FAO/WHO Expert Committee of Food Additives. 37th Meeting, 10-12 June 1990. Geneva (Switzerland): World Health Organization(WHO). pp. 365-417.
32. Joint Expert Committee on Food Additives (JECFA). 1995. Ochratoxin A. Joint FAO/WHO Expert Committee of Food Additives. 44th Meeting, Technical Report Series Number 859. Geneva (Switzerland): World Health Organization (WHO).
33. Joint Expert Committee on Food Additives (JECFA). 2001. Ochratoxin A. In: Safety evaluation of certain mycotoxins in food. Joint FAO/WHO Expert Committee of Food Additives, 56th Meeting, February 6-15, 2001. Geneva (Switzerland): WHO Food Additives Series No. 47. IPCS-WHO, Geneva. pp 281-415.
34. Joint Expert Committee on Food Additives (JECFA). 2007. Summary and conclusions. Joint FAO/WHO Expert Committee of Food Additives. 68th Meeting, 19-28 June 2007. Geneva (Switzerland): World Health Organization (WHO).
35. Kamp HG, Eisenbrand G, Janzowski C, Kiossev J, Latendresse JR, Schlatter J, Turesky RJ. 2005. ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats. Mol Nutr Food Res. 49:1160-1167.
36. Kanisawa M, Suzuki S. 1978. Induction of renal and hepatic tumors in mice by ochratoxin A, a mycotoxin. Gann. 69:599-600.
37. Karpinski K, Nargundkar M. 1992. Technical Report No. E451311-001 (unpublished). Bureau of Biostatistics and Computer Applications, Food Directorate, Health Canada, Ottawa (Canada).
38. Kempthorne O. 1952. The design and analysis of experiments. New York (UK): Wiley. pp. 271-275.
39. Krogh P, Axelsen NH, Elling F, Gyrd-Hansen N, Hald B, Hyldgaard-Jensen J, Larsen AE, Madsen A, Mortensen HP, Moller T, Petersen OK, Ravnskov U, Rostgaard M, Aalund O. 1974. Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A contaminated feed. Acta Pathologica Microbiologica Immunologica Scandinavica Suppl. 246:1-21.
40. Krogh P, Elling F, Friis C, Hald B, Larsen AE, Lillehoj EB, Madsen A, Mortensen HP, Rasmussen F, Ravnskov U. 1979. Porcine nephropathy induced by long-term ingestion of ochratoxin A. Vet Pathol. 16:466-475.
41. Krogh P, Gyrd-Hansen N, Hald B, Larsen S, Nielsen JP, Smith M, Ivanoff C, Meisner H. 1988. Renal enzyme activities in experimental ochratoxin A-induced porcine nephropathy: Diagnostic potential of phosphoenolpyruvate carboxykinase and gamma-glutamyl transpeptidase activity. J Toxicol Environ Hlth. 23:1-14.
42. Kuiper-Goodman T. 1996. Risk assessment of ochratoxin A: an update. Food Addit Contam. 13(Suppl. 1):53-57.
43. Kuiper-Goodman T. 2004. Risk assessment and risk management of mycotoxins in food. In: Magan N, Olsen M, editors. Mycotoxins in food. Detection and control. Boca Raton (FL): CRC Press LLC. pp. 3-31.
44. Kuiper-Goodman T, Ominski K, Marquardt RR, Malcolm S, McMullen E, Lombaert GA, Morton T.1993. Estimating human exposure to ochratoxin A in Canada. In: Creppy EE, Castegnaro M, Dirheimer G, editors. Human ochratoxicosis and its pathologies. Volume 231, INSERM, Montrouge (France): John Libbey Eurotext. pp. 167-174.
45. Kuiper-Goodman T, Scott PM. 1989. Risk assessment of the mycotoxin ochratoxin A. Biomed Environ Sci. 2:179-248.
46. Lambe J. 2002. The use of food consumption data in assessments of exposure to food chemicals including the application of probabilistic modelling. Proc. Nutrit. Soc. 61:11-18.
47. Lock EA, Hard GC. 2004. Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. Crit Rev Toxicol. 34:211-299.
48. Lombaert GA, Pellaers P, Chettiar M, Lavalee D, Scott PM, Lau BPY. 2002. Survey of Canadian retail coffees for ochratoxin A. Food Addit Contam. 19:869-877.
49. Lombaert GA, Pellaers P, Neumann G, Kitchen D, Huzel V, Trelka R, Kotello S, Scott PM. 2004. Ochratoxin A in dried vine fruits on the Canadian retail market. Food Addit Contam. 21:578-585.
50. Lombaert GA, Pellaers P, Roscoe V, Mankotia M, Neil R, Scott PM. 2003. Mycotoxins in infant cereal foods from the Canadian retail market. Food Addit Contam. 20:494-504.
51. Mally A, Pepe G, Ravoori S, Fiore M, Gupta RC, Dekant W, Mosesso P. 2005b. Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem Res Toxicol. 18:1253-1261.
52. Mally A, Volkel W, Amberg A, Kurz M, Wanek P, Eder E, Hard G, Dekant W. 2005a. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats. Chem Res Toxicol. 18:1242-1252.
53. Mally A, Zepnik H, Wanek P, Eder E, Dingley K, Ihmels H, Volkel W, Dekant W. 2004. Ochratoxin A: lack of formation of covalent DNA adducts. Chem Res Toxicol. 17:234-242.
54. Manderville RA. 2005. A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduc-tion. Chem Res Toxicol. 18:1091-1097.
55. Mantle P, Kulinskaya E, Nestler S. 2005. Renal tumourigen-esis in male rats in response to chronic dietary ochratoxin A. Food Addit Contam. 22(Suppl. 1):58-64.
56. Munro IC, Moodie CA, Kuiper-Goodman T, Scott PM, Grice HC. 1974. Toxicologic changes in rats fed graded dietary levels of ochratoxin A. Toxicol Appl Pharmacol. 28:180-184.
57. National Research Council (NRC). 1986. National Research Council Subcommittee on Criteria for Dietary Evaluation. Nutrient adequacy: assessment using food consumption surveys. Washington (DC): National Academies Press.
58. National Toxicology Program (NTP). 1989. Toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies). Technical Report Number 358. Research Triangle Park (NC): Department of Health and Human Services.
59. Ng W, Mankotia M, Pantazopoulos P, Neil RJ, Scott PM. 2004. Ochratoxin A in wine and grape juice sold in Canada. Food Addit Contam. 21:971-981.
60. Ng W, Mankotia M, Pantazopoulos P, Neil RJ, Scott PM. 2009. Survey of dry pasta for ochratoxin A. J Food Protect. 72:890-893.
61. Nusser SM, Carriquiry AL, Dodd KW, Fuller WA. 1996. A semi-parametric transformation approach to estimating usual daily intake distributions. J Am Stat Assoc. 91:1440-1449.
62. O'Brien E, Dietrich DR. 2005. Ochratoxin A: The continuing enigma. Crit Rev Toxicol. 35:33-60.
63. O'Brien J, Renwick AG, Constable A, Dybing E, Muller DJG, Schlatter J, Slob W, Tueting W, van Benthem J, Williams GM, Wolfreys A. 2006. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal. Food Chem Toxicol. 44:1613-1635.
64. Obrecht-Pflumio S, Chassat T, Dirheimer G, Marzin D. 1999. Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes. Mutat Res. 446:95-102.
65. Olsen M, Thorup I, Knudsen I, Larsen JJ, Hald B, Olsen J. 1991. Health evaluation of ochratoxin A in food products. Number 545. Copenhagen (Denmark): Nordic Council of Ministers.
66. Petersen BJ. 2000. Probabilistic modelling: theory and practice. Food Addit Contam. 17:591-599.
67. Petzinger E, Ziegler K. 2000. Ochratoxin A from a toxicological perspective. J Vet Pharmacol Ther. 23:91-98.
68. Pfohl-Leszkowicz A, Castegnaro M. 2005. Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation. Food Addit Contam. 22(Suppl. 1):75-87.
69. Pfohl-Leszkowicz A, Manderville RA. 2007. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res. 51:61-99.
70. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. 2007. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephro-pathy and urinary tract tumors. Mol Nutr Food Res. 51:1131-1146.
71. Rached E, Hard GC, Blumbach K, Weber K, Draheim R, Lutz WK, Ozden S, Steger U, Dekant W, Mally A. 2007. Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/N rats. Toxicol Sci. 97:288-298.
72. Roscoe V, Lombaert GA, Huzel V, Neumann G, Melietio J, Kitchen D, Kotello S, Krakalovich T, Trelka R, Scott PM. 2008. Mycotoxins in breakfast cereals from the Canadian retail market: a 3-year survey. Food Addit Contam. 25:347-355.
73. Ryden E, Ekstrom CHL, Hellmer L, Bolcsfoldi G. 2000. Comparison of the sensitivities of Salmonella typhimurium strains TA102 and TA2638A to 16 mutagens. Mutagenesis. 15:495-502.
74. Schlatter C, Studer-Rohr J, Rasonyi T. 1996. Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit Contam. 13(Suppl.):43-44.
75. SCOOP. 2002. Assessment of dietary intake of ochratoxin A by the population of EU Member States. Report of Tasks for Scientific Cooperation Number 3.2.7. (Miraglia M and Brera C, Coordinators), Rome (Italy)/ISS, National Institute of Health.
76. Scott PM. 2005. Biomarkers of human exposure to ochratoxin A. Food Addit Contam. 22(Suppl. 1):99-107.
77. Scott PM, Kanhere SR. 1995. Determination of ochratoxin A in beer. Food Addit Contam. 12:591-598.
78. Scott PM, Kanhere SR, Lau BP, Lewis DA, Hayward S, Ryan JJ, Kuiper-Goodman T. 1998. Survey of Canadian human blood plasma for ochratoxin A. Food Addit Contam. 15:555-562.
79. Scudamore KA, Banks J, MacDonald SJ. 2003. Fate of ochratoxin A in the processing of whole wheat grains during milling and bread production. Food Addit Contam. 20:1153-63.
80. Slob W. 1993. Modeling long-term exposure of the whole population to chemicals in food. Risk Analysis. 16:195-200.
81. Stefanovic V, Toncheva D, Atanasova S, Polenakovic M. 2006. Etiology of Balkan Endemic Nephropathy and associated urothelial cancer. Am J Nephrol. 26:1-11.
82. Tennant R. 1994. Non-genotoxic chemical carcinogens: Evidence for multiple mechanisms. In: Cockburn A, Smith L, editors. Non-genotoxic carcinogenesis. Ernst Schering Research Foundation Workshop Number 10. Berlin (Germany): Springer. pp. 1-16.
83. Thuvander A, Moller T, Barbieri HE, Jansson A, Salomonsson AC, Olsen M. 2001. Dietary intake of some important mycotoxins by the Swedish population. Food Addit Contam. 18:696-706.
84. Tozlovanu M, Faucet-Marquis V, Pfohl-Leszkowicz A, Manderville RA. 2006. Genotoxicity of the hydroquinone metabolite of ochratoxin A: structure-activity relation-ships for covalent DNA adduction. Chem Res Toxicol. 19:1241-1247.
85. Tressou J, Crepet A, Bertail P, Feinberg MH, Leblanc JCh. 2004a. Probabilistic exposure assessment to food chemicals based on extreme value theory. Application to heavy metals from fish and sea products. Food Chem Toxicol. 42:1349-1358.
86. Tressou J, Leblanc JCh, Feinberg M, Bertail P. 2004b. Statistical methodology to evaluate food exposure to a contaminant and influence of sanitary limits: application to ochratoxin A. Regulat Toxicol Pharmacol. 40:252-263.
87. Turesky RJ. 2005. Perspective: ochratoxin A is not a genotoxic carcinogen. Chem Res Toxicol. 18:1082-1090.
88. US Department of Agriculture (USDA). 2000. CSFII data set and documentation: the 1994-1996, 1998 continuing surveys of food intakes by individuals. Beltsville (MD): Food Surveys Research Group, Beltsville Human Nutrition Research Center, Agricultural Research Service.
89. US Environmental Protection Agency (USEPA). 2005. Guidelines for carcinogen risk assessment. EPA/630/P-03/001F. Washington (DC): USEPA.
90. World Health Organization/International Programme on Chemical Safety (WHO-IPCS). 1999. Principles for the assessment of risks to human health from exposure to chemicals. Environmental Health Criteria Number 210. Geneva (Switzerland): WHO.
91. Zepnik H, Pahler A, Schauer U, Dekant W. 2001. Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites? Toxicol Sci. 59:59-67.